Cargando…
TMIGD2 as a potential therapeutic target in glioma patients
INTRODUCTION: Among all types of central nervous system cancers, glioma remains the most frequent primary brain tumor in adults. Despite significant advances in immunomodulatory therapies, notably immune checkpoint inhibitors, their effectiveness remains constrained due to glioma resistance. The dis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227580/ https://www.ncbi.nlm.nih.gov/pubmed/37261362 http://dx.doi.org/10.3389/fimmu.2023.1173518 |